Copyright
©The Author(s) 2015.
World J Gastroenterol. May 21, 2015; 21(19): 5901-5909
Published online May 21, 2015. doi: 10.3748/wjg.v21.i19.5901
Published online May 21, 2015. doi: 10.3748/wjg.v21.i19.5901
Table 1 Clinical patient characteristics n (%)
| Variable | Overall (n = 40) number | Locally advanced (n = 23) number | Disseminated (n = 17) number | P value |
| Age: median/range (yr) | 63/37-79 | 69/37-79 | 62/42-79 | 0.38 |
| Sex | 0.66 | |||
| Male | 31 (77) | 17 (74) | 14 (82) | |
| Female | 9 (23) | 6 (26) | 3 (18) | |
| Performance status | 0.73 | |||
| 0 | 18 (45) | 11 (48) | 7 (41) | |
| 1-2 | 22 (55) | 12 (52) | 10 (59) | |
| Weight loss | 0.61 | |||
| < 5% | 11 (28) | 7 (30) | 4 (24) | |
| 5%-10% | 12 (30) | 7 (30) | 5 (29) | |
| > 10% | 17 (42) | 9 (40) | 8 (47) | |
| Tumour location | 0.85 | |||
| Upper third | 20 (50) | 12 (52) | 8 (47) | |
| Middle third | 15 (37.5) | 8 (35) | 7 (41) | |
| Lower third | 5 (12.5) | 3 (13) | 2 (12) | |
| Tumour clinical stage (AJCC 2010) | 0.39 | |||
| cT1-T3 | 32 (80) | 20 (87) | 12 (71) | |
| cT4 | 8 (20) | 3 (13) | 5 (29) | |
| Nodal involvement (AJCC 2010) | 0.014 | |||
| cN0 | 20 (50) | 16 (70) | 4 (23) | |
| cN1-N3 | 20 (50) | 7 (30) | 13 (77) | |
| Histology | 0.45 | |||
| Intestinal type | 32 (80) | 17 (74) | 15 (88) | |
| Diffuse type | 8 (20) | 6 (26) | 2 (12) | |
| Histological grade | 0.71 | |||
| G1-G2 | 12 (30) | 8 (35) | 4 (24) | |
| G3 | 18 (45) | 9 (39) | 9 (52) | |
| Not specified | 10 (25) | 6 (26) | 4 (24) | |
| CA19.9 median (range), IU/mL | 10.65 (2-159674) | 9.43 (2.0-12571) | 11.07 (2.0-159674) | 0.10 |
| CEA median (range), IU/mL | 2.86 (0.5-514) | 2.09 (0.5-117) | 9.04 (0.7-514) | 0.17 |
- Citation: Grabinska K, Pelak M, Wydmanski J, Tukiendorf A, d’Amico A. Prognostic value and clinical correlations of 18-fluorodeoxyglucose metabolism quantifiers in gastric cancer. World J Gastroenterol 2015; 21(19): 5901-5909
- URL: https://www.wjgnet.com/1007-9327/full/v21/i19/5901.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i19.5901